Congratulations to Prof. Douglas Hanahan. The emeritus scientist of the Lausanne branch of Ludwig Cancer Research and emeritus professor at EPFL’s Swiss Institute for Experimental Cancer Research (ISREC) has won the prestigious Pezcoller-AACR award for his groundbreaking contributions to cancer biology; a well-deserved recognition for a scientist whose work has profoundly influenced cancer research.

Once a year, World Cancer Day offers the opportunity to raise awareness of this disease around the world.

Thanks to your generosity, the ISREC Foundation can turn all contributions into a direct and tangible impact in the fight against cancer. We support innovative, life-changing research projects. 🌍 Cancer must be fought globally, but together, we can effectively tackle this disease at a local level. Every donation creates change.

Join us at our public conference on February 5th to find out how your donation impacts research and patients.

For more information click here

We wish to express our gratitude to Syslog Informatique SA, a company that is celebrating its 40^th anniversary this year. Syslog is a long-standing partner of the ISREC Foundation that has been supporting us in the field of IT accounting for over 25 years.

To mark its 40^th anniversary, the company has decided to make a donation to the ISREC Foundation, symbolizing its ongoing commitment to our cause. Many thanks to Sandro Arcioni and the entire Syslog team for their trust and support.

Link to the article (In French)

Congratulations are in order for Prof. George Coukos, director of the oncology department at UNIL-CHUV, and director of the Ludwig Institute for Cancer Research, Lausanne Branch: he has been elected as a member of the National Academy of Medicine (NAM).

This honor recognizes his groundbreaking contributions to oncology and immunotherapy. His research on the correlation between T cell infiltration and favorable prognosis in ovarian cancer has paved the way for new treatments for solid tumors. A well-deserved tribute to a career dedicated to innovation in oncology.

For more information: National Academy of Medicine Elects 100 New Members – National Academy of Medicine

Congratulations to Prof. Hall, a scientist at the Biozentrum of the University of Basel and a member of our Foundation Council as well as the President of our Scientific Board. He has received this prestigious award in recognition of his groundbreaking contributions to our understanding of the molecular mechanisms that regulate cell growth and ageing.

Michael Hall has discovered two proteins, “Gene Target of Rapamycin 1 and 2”, also known as TOR1 and TOR2, that regulate cell growth and metabolism in response to nutrients. These proteins play a central role in the ageing process and the development of age-related diseases such as cancer, diabetes and cardiovascular diseases.

These discoveries have paved the way for an important area of research that has since developed considerably.

For more information: Michael N. Hall – 2024 Balzan Prize for Biological Mechanisms of Ageing

Congratulations to Estelle Mougin, winner of this year’s Prix Pierre-François Leyvraz, an award created by the ISREC Foundation to promote interprofessionality in the field of oncology.

Estelle Mougin has been a clinical nurse in the CHUV’s oncology department since 2016. She is currently enrolled in the IUFRS (Institute of Higher Education and Research in Healthcare) Master of Science program on specialized nursing practice. As part of her studies, she is writing a dissertation aimed at defining the role of specialized nurse practitioners in the CHUV’s senology clinic. The Pierre-François Leyvraz Award was created by the ISREC Foundation in 2019, in recognition of the commitment of Prof. Pierre-François Leyvraz (former Director General of the CHUV) within its Foundation Council. This prize honors work promoting the development of interprofessionality in the oncological field.

For more information (in French): Le Prix Pierre-François Leyvraz pour Estelle Mougin – Direction des soins – CHUV